Skip to main content
Dan Landau, MD, Hematology, New York, NY

Dan Avi Landau MD


Research Fellow in Medicine, Dana-Farber Cancer Institute

Join to view full profile
  • 520 E 70th St# 341New York, NY 10021

  • Phone+1 475-202-9787

  • Fax+1 203-688-5599

Dr. Landau is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2009 - 2012
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Internal Medicine, 2007 - 2009
  • Tel Aviv University Sackler
    Tel Aviv University SacklerClass of 2002

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2016 - 2027
  • MA State Medical License
    MA State Medical License 2014 - 2017
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Journal Articles

  • Discovery of a Periosteal Stem Cell Mediating Intramembranous Bone Formation  
    John H Healey, Mathias P Bostrom, Matthew B Greenblatt, Meera Hameed, Dan Avi Landau, Nature

Lectures

  • Role and Mechanisms of Clonal Evolution in Lymphoid Malignancies 
    60th American Society of Hematology Annual Meeting - 12/2/2018
  • Continuing Conversations With the Speakers on Role and Mechanisms of Clonal Evolution in Lymphoid Malignancies 
    60th American Society of Hematology Annual Meeting - 12/1/2018
  • Multimodal Single-Cell Profiling Defines the Epigenetic Determinants of Chronic Lymphocytic Leukemia Evolution 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Developing GoT-Multi to Track Cancer Evolution and Treatment Resistance
    Developing GoT-Multi to Track Cancer Evolution and Treatment ResistanceOctober 13th, 2025
  • Cancer Progression Illuminated by New Multi-Omics Tool
    Cancer Progression Illuminated by New Multi-Omics ToolOctober 10th, 2025
  • New Multi-Omics Tool Sheds Light on Cancer Progression
    New Multi-Omics Tool Sheds Light on Cancer ProgressionOctober 10th, 2025

Grant Support

  • Defining the determinants of long term CAR-T persistenceUNIVERSITY OF PENNSYLVANIA2026–2031
  • Defining the determinants of long term CAR-T persistenceUNIVERSITY OF PENNSYLVANIA2026–2031
  • Defining targetable vulnerabilities in UBA1-mutated VEXAS HSCs for clonal eradicationNEW YORK UNIVERSITY SCHOOL OF MEDICINE2025–2029
  • Center for Integrated Cellular AnalysisNEW YORK GENOME CENTER2020–2029
  • Precision single-cell mapping of chromatin-associated protein activity by molecular footprinting to chart disruptions to gene regulation and dissect tumor heterogeneity in cancerWEILL MEDICAL COLL OF CORNELL UNIV2025–2028

Other Languages

  • Spanish, French, Hebrew

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: